Download PDF
Horm Metab Res 2023; 55(03): 184-190
DOI: 10.1055/a-2014-4589
Original Article: Endocrine Care

Control of Thyroid Dysfunction in Spanish Population Registered in the Primary Care Clinical Database: An Analysis of the Proportion of Patients with Thyrotropin Values Outside the Reference Range

Juan J. Díez 
1   Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana Majadahonda, Spain
,
Pedro Iglesias
1   Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana Majadahonda, Spain
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Inadequate control of thyroid dysfunction is common and has deleterious health consequences. Our objective was to determine the prevalence of TSH values outside the reference range, as an indicator of inadequate control of hypothyroidism and hyperthyroidism in patients undergoing treatment for thyroid dysfunction in Spain. An observational, retrospective, non-interventional study was conducted using the Primary Care Clinical Database (BDCAP). Patients treated with thyroid hormone for hypothyroidism and with antithyroid drugs for hyperthyroidism were identified. We assessed serum TSH concentration, considering values from 0.4 to 4.0 mU/l as the reference interval. We found 360 313 people with hypothyroidism on thyroid hormone replacement and 9239 with hyperthyroidism on antithyroid drugs therapy. TSH values outside the reference range in hypothyroid subject were detected in 126 866 (35.20%) people, of whom 107 205 (29.75%) had TSH>4.0 mU/l, suggesting inappropriately low doses of levothyroxine, and 19 661 (5.46%) had TSH<0.4 mU/l, suggesting inappropriate over replacement. In the hyperthyroid group, TSH values outside the reference range were observed in 4252 (46.02%) patients. There were 2833 (30.66%) patients with TSH<0.4 mU/l, suggesting undertreatment, and 1419 (15.36%) with TSH>4.0 mU/l, suggesting overtreatment with antithyroid medication. People over 65 years of age had a lower frequency of undertreatment of hypothyroidism and a lower frequency of overtreatment and undertreatment of hyperthyroidism. In conclusion, our results suggest that inadequate control of thyroid dysfunction, due to its high frequency and its consequences for health, is a public health problem that should be addressed by clinicians and health authorities.

Key words

hypothyroidism - thyroid - hyperthyroidism - treatment - monitoring - adequacy - BDCAP


Publication History

Received: 28 September 2022

Accepted after revision: 10 January 2023

Article published online:
09 February 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Hollowell JG, Staehling NW, Flanders WD. et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-499
    CrossrefPubMedGoogle Scholar
  • 2 Canaris GJ, Manowitz NR, Mayor G. et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526-534
    CrossrefPubMedGoogle Scholar
  • 3 Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F. et al. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab 2014; 99: 923-931
    CrossrefPubMedGoogle Scholar
  • 4 Santos Palacios S, Llavero Valero M, Brugos-Larumbe A. et al. Prevalence of thyroid dysfunction in a large southern European population. Analysis of modulatory factors. The APNA study. Clin Endocrinol (Oxf) 2018; 89: 367-375
    CrossrefPubMedGoogle Scholar
  • 5 Bjoro T, Holmen J, Krüger O. et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol 2000; 143: 639-647
    CrossrefPubMedGoogle Scholar
  • 6 Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007; 92: 4575-4582
    CrossrefPubMedGoogle Scholar
  • 7 Díez JJ. Hypothyroidism in patients older than 55 years: an analysis of the etiology and assessment of the effectiveness of therapy. J Gerontol A Biol Sci Med Sci 2002; 57: M315-M320
    CrossrefPubMedGoogle Scholar
  • 8 Parle JV, Franklyn JA, Cross KW. et al. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract 1993; 43: 107-109
    PubMedGoogle Scholar
  • 9 Vaisman F, Coeli CM, Ward LS. et al. How good is the levothyroxine replacement in primary hypothyroidism patients in Brazil? Data of a multicentre study. J Endocrinol Invest 2013; 36: 485-488
    PubMedGoogle Scholar
  • 10 Vigário Pdos S, Vaisman F, Coeli CM. et al. Inadequate levothyroxine replacement for primary hypothyroidism is associated with poor health-related quality of life-a Brazilian multicentre study. Endocrine 2013; 44: 434-440
    CrossrefPubMedGoogle Scholar
  • 11 Paschou SA, Bletsa E, Stampouloglou PK. et al. Thyroid disorders and cardiovascular manifestations: an update. Endocrine 2022; 75: 672-683
    CrossrefPubMedGoogle Scholar
  • 12 Nanchen D, Gussekloo J, Westendorp RG. et al. Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J Clin Endocrinol Metab 2012; 97: 852-861
    CrossrefPubMedGoogle Scholar
  • 13 Gencer B, Collet TH, Virgini V. et al. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation 2012; 126: 1040-1049
    CrossrefPubMedGoogle Scholar
  • 14 Base de datos Clínicos de Atención Primaria. BDCAP. Ministerio de Sanidad, Servicios Sociales e Igualdad (MSSSI). Documento actualizado 2014. Available at: href="https://www.sanidad.gob.es/eu/estadEstudios/estadisticas/estadisticas/estMinisterio/SIAP/Diseno_BDCAP.pdf
    PubMed
  • 15 Díez JJ, Iglesias P, García A. et al. Thyroid dysfunction in patients older than 75 years: an analysis of inadequacy of treatment and therapeutic control. Eur Geriatr Med 2022; 13: 127-137
    CrossrefPubMedGoogle Scholar
  • 16 Base de Datos Clínicos de Atención Primaria – BDCAP. Portal estadístico. Área de Inteligencia y de Gestión. Available at: https://pestadistico.inteligenciadegestion.mscbs.es/publicoSNS/S/base-de-datos-de-clinicos-de-atencion-primaria-bdcap. Visited on 27 Jul 2022
    PubMed
  • 17 Okosieme OE, Belludi G, Spittle K. et al. Adequacy of thyroid hormone replacement in a general population. QJM 2011; 104: 395-401
    CrossrefPubMedGoogle Scholar
  • 18 Somwaru LL, Arnold AM, Joshi N. et al. High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J Clin Endocrinol Metab 2009; 94: 1342-1345
    CrossrefPubMedGoogle Scholar
  • 19 Díez JJ. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management. Gerontology 2003; 49: 316-323
    CrossrefPubMedGoogle Scholar
  • 20 Diez JJ, Iglesias P. Hypothyroidism in the middle aged and elderly: clinical aspects. In: Preedy VR, Burrow GN, Watson R (eds). Comprehensive Handbook of Iodine. Oxford: Academic Press; 2009: 1033-1039
    Google Scholar
  • 21 Garber JR, Cobin RH, Gharib H. et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid 2012; 22: 1200-1235
    CrossrefPubMedGoogle Scholar
  • 22 Pearce SH, Brabant G, Duntas LH. et al. 2013 ETA Guideline: management of subclinical hypothyroidism. Eur Thyroid J 2013; 2: 215-228
    CrossrefPubMedGoogle Scholar
  • 23 Biondi B, Bartalena L, Cooper DS. et al. The 2015 European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism. Eur Thyroid J 2015; 4: 149-163
    CrossrefPubMedGoogle Scholar
  • 24 Ross DS, Burch HB, Cooper DS. et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 2016; 26: 1343-1421
    CrossrefPubMedGoogle Scholar
  • 25 Díez JJ, Oleaga A, Álvarez-Escolá C. et al. Clinical guideline for management of patients with low risk differentiated thyroid carcinoma. Endocrinol Nutr 2015; 62: e57-e72
    PubMedGoogle Scholar
  • 26 Lillevang-Johansen M, Abrahamsen B, Jørgensen HL. et al. Duration of hyperthyroidism and lack of sufficient treatment are associated with increased cardiovascular risk. Thyroid 2019; 29: 332-340
    CrossrefPubMedGoogle Scholar
  • 27 Collet TH, Gussekloo J, Bauer DC. et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 2012; 172: 799-809
    CrossrefPubMedGoogle Scholar
  • 28 Song E, Koo MJ, Noh E. et al. Risk of diabetes in patients with long-standing Graves’ disease: a longitudinal study. Endocrinol Metab (Seoul) 2021; 36: 1277-1286
    CrossrefPubMedGoogle Scholar
  • 29 Blum MR, Bauer DC, Collet TH. et al. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA 2015; 313: 2055-2065
    CrossrefPubMedGoogle Scholar
  • 30 Selmer C, Olesen JB, Hansen ML. et al. Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. J Clin Endocrinol Metab 2014; 99: 2372-2382
    CrossrefPubMedGoogle Scholar
  • 31 Danese MD, Ladenson PW, Meinert CL. et al. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 2000; 85: 2993-3001
    PubMedGoogle Scholar
  • 32 Díez JJ, Iglesias P. An analysis of the relative risk for hypothyroidism in patients with type 2 diabetes. Diabet Med 2012; 29: 1510-1514
    CrossrefPubMedGoogle Scholar
  • 33 Pearce EN. Update in lipid alterations in subclinical hypothyroidism. J Clin Endocrinol Metab 2012; 97: 326-333
    CrossrefPubMedGoogle Scholar
  • 34 Cai P, Peng Y, Chen Y. et al. Blood pressure characteristics of subclinical hypothyroidism: an observation study combined with office blood pressure and 24-h ambulatory blood pressure. J Hypertens 2021; 39: 453-460
    CrossrefPubMedGoogle Scholar
  • 35 Gong N, Gao C, Chen X. et al. Endothelial function in patients with subclinical hypothyroidism: a meta-analysis. Horm Metab Res 2019; 51: 691-702
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 Rodondi N, den Elzen WP, Bauer DC. et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010; 304: 1365-1374
    CrossrefPubMedGoogle Scholar
  • 37 Díez JJ, Iglesias P, Gómez-Mateos MÁ. Management of primary hypothyroidism in adults: an analysis of the results of a survey in 546 primary care physicians. Endocrinol Diabetes Nutr 2022; 69: 289-298
    CrossrefPubMedGoogle Scholar
  • 38 Morris JC. How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement?. Clin Endocrinol (Oxf) 2009; 70: 671-673
    CrossrefPubMedGoogle Scholar
  • 39 Robertson HM, Narayanaswamy AK, Pereira O. et al. Factors contributing to high levothyroxine doses in primary hypothyroidism: an interventional audit of a large community database. Thyroid 2014; 24: 1765-1771
    CrossrefPubMedGoogle Scholar
  • 40 Díez JJ, Iglesias P, Gómez-Mateos MA. Educational and research needs in hypothyroidism of primary care physicians in the Community of Madrid. Endocrinol Diabetes Nutr 2022; 69: 828-836 DOI: 10.1016/j.endinu.2021.10.014.
    CrossrefPubMedGoogle Scholar